The National Cancer Institute (NCI) solicits grant applications proposing exploratory research projects focused on the inception and early stage development of highly innovative cancer-relevant technologies.
The emphasis of this FOA is on technically innovative molecular analysis tools with the potential to add a new quality to the investigations of the molecular basis of cancer (e.g., by facilitating the detection of cancer-related characteristics/alterations at the molecular and cellular levels of organization and function). These technologies may be intended for molecular analyses in vitro, in situ, and/or in vivo. Responsive “technologies” encompass relevant methods, techniques, tools, instrumentation, and devices (but not software or informatics solutions).
This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available. To facilitate selection, a separate notice in the NIH Guide for Grants and Contracts provides brief cross-comparison and links to all the IMAT FOAs. See
NOT-CA-08-003.
